News

Point-of-care medication dispensing offers a return to a more straightforward approach, common to physician practices ...
CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
Rite Aid, which filed for Chapter 11 bankruptcy in October 2023, recently updated its restructuring plans amid ongoing ...
Store closures are being implemented in waves, with some locations closing immediately and others expected to cease ...
CVS Health announced it will exit the Affordable Care Act (ACA) insurance market in 2026, leaving roughly 1 million ... CVS is not alone in reshaping its footprint. Walgreens plans to close 500 stores ...
In late 2022 CVS and Walgreens agreed to pay a total ... amid slowing sales and shrinking market share. Walgreens announced it was to close around 1,200 stores nationwide in the fall of last ...
CVS raises profit forecast, to exit Obamacare market as turnaround gains steam ... Retail & Consumercategory· October 15, 2024 Walgreens to shut 1,200 stores as CEO Wentworth seeks turnaround ...
Walgreens shareholders could also receive an additional $3 in cash from future monetization of the company's debt and equity interests in VillageMD. The company's market value has shrunk to just ...
With Walgreens (NASDAQ:WBA) agreeing to a subpar M&A deal with private equity firm Sycamore Partners, CVS Health (NYSE ... After commanding over $100B in market cap in 2015, Deerfield, Illinois ...
Many of the company's missteps were under former CEO Stefano Pessina, also its largest single shareholder, whose 2007-14 tenure at the helm saw Walgreens' market ... now a good exit candidate ...
but it never captured significant market share against the three largest PBMs: UnitedHealth's Optum RX (UNH), CVS's Caremark, and Cigna's Express Scripts (CI). Walgreens stock climbed when the ...
WALGREENS Boots Alliance will be taken private by Sycamore Partners for US$10 billion, the buyout firm said on Thursday, closing out nearly a century of trading on public markets for the US pharmacy ...